HomeLiterature Search
Popular searches
Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a compar…

Lowry(Kathryn P),Lee(Janie M),Kong(Chung Y),… Cancer 2012-05-18

...BRCA2, 77.63 years). When radiation risk was included, a small proportion of diagnosed cancers was attributable to radia...

Novel germline PALB2 truncating mutations in African American breast cancer pat…

Zheng(Yonglan),Zhang(Jing),Niu(Qun),Huo(Dezh… Cancer 2012-04-30

...BRCA2 proteins and is responsible for facilitating BRCA2-mediated DNA repair. Truncating mutations in the PALB2 gene rep...

An emerging entity: pancreatic adenocarcinoma associated with a known BRCA muta…

Lowery(Maeve A),Kelsen(David P),Stadler(Zsof… Oncologist 2012-04-26

BRCA1 and BRCA2 germline mutations are associated with an elevated risk for pancreas adenocarcinoma (PAC). Other BRCA-as...

Genomic instability in breast and ovarian cancers: translation into clinical pr…

Vollebergh(Marieke A),Jonkers(Jos),Linn(Sabi… Cell Mol Life Sci 2012-03-05

...BRCA2. BRCA-associated breast and ovarian cancers are hallmarked by genomic instability and high sensitivity to DNA doub...

Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Sp…

de Juan Jiménez(Inmaculada),Esteban Cardeños… Fam Cancer 2012-07-12

The true prevalence of BRCA1/BRCA2 (BRCAs) germline mutations in sporadic breast or ovarian cancer (SBC/SOC) in Caucasia...

BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients.

Keshavarzi(Fatemeh),Javadi(Gholam Reza),Zein… Fam Cancer 2012-07-12

...BRCA2 are responsible for a substantial proportion of high-risk breast and breast/ovarian cancer families (Collaborative...

Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation car…

Cibula(David),Zikan(Michal),Dusek(Ladislav),… Expert Rev Anticancer Ther 2012-01-10

...BRCA2 (OR: 1.03; p = 0.788) mutation carriers or in case-case studies in BRCA1/2 carriers (OR: 0.80; p = 0.147). Signifi...

Primary transitional cell carcinoma of the fallopian tube.

Elsokkari(Ihab),Napaki(Sarbar),Greening(Sian… J Obstet Gynaecol Res 2012-02-23

...BRCA2 mutations was undertaken and did not reveal any mutation or unclassified variants. Multiplex ligation-dependent pr...

RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumo…

Suwaki(Natsuko),Klare(Kerstin),Tarsounas(Mad… Semin Cell Dev Biol 2012-06-04

...BRCA2 tumour suppressor, through the recently reported links between RAD51 paralog deficiencies and tumorigenesis trigge...

The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up…

Helleday(Thomas) Mol Oncol 2012-02-01

...BRCA2 genes through the concept of synthetic lethality. It is suggested that PARP inhibitors cause an increase in DNA si...

Previous 229 230 231 232 233 234 235 236 237 Next Vol. 233 / of 633

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com